Ladenburg Thalmann Financial Services’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$9K	Hold	575	–	–	﹤0.01%	4553
2019 Q3	$9K	Hold	575	–	–	﹤0.01%	4460
2019 Q2	$7K	Sell	575 -100	-15%	-$1.21K	﹤0.01%	4604
2019 Q1	$8K	Hold	675	–	–	﹤0.01%	4489
2018 Q4	$10K	Hold	675	–	–	﹤0.01%	4301
2018 Q3	$12K	Buy	675 +220	+48%	+$3.81K	﹤0.01%	4203
2018 Q2	$9K	Hold	455	–	–	﹤0.01%	4328
2018 Q1	$9K	Hold	455	–	–	﹤0.01%	4328
2017 Q4	$10K	Buy	455 +150	+49%	+$4.8K	﹤0.01%	4200
2017 Q3	$11K	Buy	+305	New	+$11.4K	﹤0.01%	4050

Other funds holding OPNT

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Ladenburg Thalmann Financial Services's OPNT Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Opiant Pharmaceuticals, Inc. Common Stock (OPNT) position steady in Q4 2019 at 575 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4553.

Ladenburg Thalmann Financial Services first reported a position in OPNT in Q3 2017 and has held it in 10 quarters since. The position peaked at $12K in Q3 2018. 28 funds tracked by Wall St. Rank hold OPNT as of Q4 2019.

Ladenburg Thalmann Financial Services held 575 shares of Opiant Pharmaceuticals, Inc. Common Stock worth $9K as of Q4 2019.
Ladenburg Thalmann Financial Services left its Opiant Pharmaceuticals, Inc. Common Stock share count unchanged in Q4 2019.
Opiant Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4553 holding.
Ladenburg Thalmann Financial Services first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2017 and has held it in 10 quarters since.
Ladenburg Thalmann Financial Services's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $12K in Q3 2018.
28 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.